Treatment Of Hirsutism With Myo-inositol: A Prospective Clinical Study

効果 なし
試験方法 コホート法
試験期間 6+ ヶ月
被験者数 46
性別 女性
年齢 18-29
体型 肥満
この研究の注釈：

6 months of treatment with 2g inositol to women with hirsutism was associated with reductions in the symptoms directly as well as improvements in insulin sensitivity.

Metabolic And Hormonal Effects Of Myo-inositol In Women With Polycystic Ovary Syndrome: A Double-blind Trial

効果 減少
試験方法 二重盲検法
試験期間 1-6 ヶ月
被験者数 42
性別 男女
年齢 18-29, 30-44
体型 肥満
この研究の注釈：

Supplementation of 4,000mg inositol daily for a period of 12-16 weeks in women with PCOS was able to improve tolerance to glucose and glucose handling (as well as reduce the amount of insulin secreted in response to a meal) with minor benefits to cardiovascular health as well.

One-year Effects Of Myo-inositol Supplementation In Postmenopausal Women With Metabolic Syndrome

効果 減少
試験方法 二重盲検法
試験期間 6+ ヶ月
被験者数 80
性別 女性
年齢 45-64, 65+
体型 肥満
この研究の注釈：

Supplementation of myo-inositol at 2g twice daily for the course of one year in postmenopausal women with metabolic syndrome was associated with improvements on all metabolic parameters measured (cardiovascular health and glucose metabolism) although no influence on weight was noted.

Myo-inositol Treatment Increases Serum Plasmalogens And Decreases Small Dense LDL, Particularly In Hyperlipidemic Subjects With Metabolic Syndrome

効果 なし
試験方法 コホート法
試験期間 1-2 週間
被験者数 17
性別 男女
年齢 30-44, 45-64
体型 肥満
この研究の注釈：

Two weeks supplementation of _myo_-inositol at 5g (first week) and 10g (second week) was able to increase circulating levels of choline plasmalogen, which is thought to be the reason behind a reduction in LDL-C. These changes were not present in persons without metabolic syndrome.